Clinical Trials Directory

Trials / Sponsors / Gemin X

Gemin X

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma
Metastatic Melanoma
Phase 1 / Phase 22008-06-01
CompletedA Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung C
Extensive-stage Small Cell Lung Cancer
Phase 1 / Phase 22008-05-01
CompletedStudy of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
AML
Phase 22008-04-01
CompletedSafety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab f
Lymphoma, Follicular
Phase 22007-03-01
WithdrawnSafety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas
Solid Tumors and Lymphomas
Phase 12007-03-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes
Phase 22006-12-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-S
Lung Cancer
Phase 1 / Phase 22006-10-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Rel
Mantle-Cell Lymphoma
Phase 1 / Phase 22006-10-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplas
Myelofibrosis
Phase 22006-07-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
Hodgkin's Lymphoma
Phase 22006-07-01
CompletedSafety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies
Hematological Malignancies
Phase 12005-10-01
CompletedA Phase I/II Study of GX15-070MS in Untreated CLL
Chronic Lymphocytic Leukemia
Phase 12004-09-01